Accessibility Help | Sitemap | Contact Us | Customer Support CALL +27 11 315 0445
South Africa Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support

V.A.C. Therapy Clinical Data

One of the most extensive bodies of evidence in Negative Pressure and Advanced Wound Care

For more than 10 years, V.A.C.® Therapy with V.A.C. GranuFoam Dressings has set the standard for fast20 and effective5 wound healing leading to a significant improvement of the patient’s Quality of Life1 and the cost effectiveness3 for the health care providers. With more than 8,000,000 wounds treated worldwide*, carers rely on the integrated V.A.C. Therapy System to deliver healing outcomes they can trust. As of 12 May 2014, this body of evidence includes:

  • 41 Randomised Controlled Trials (RCTs)
  • More than 918 peer-reviewed articles
  • More than 931 abstracts presented at clinical conferences
  • 71 medical textbook citations

You can view selected article citations.

The Only NPWT Device that is Clincally Proven

The vast majority of published data relating to NPWT products are based on the integrated V.A.C. Therapy System, using the unique GranuFoam interface. This proprietary foam, in combination with negative pressure, creates an environment that promotes fast20 and effective5 wound healing. These clinically proven mechanisms of action differentiate KCI Integrated system from other NPWT products.

Learn more about the mechanisms of V.A.C. Therapy with V.A.C. GranuFoam Dressings.

*As of 12/31/13 KCI data on file

  • Share on
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us

Copyright © 1998 – 2013 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.ZA
The information included in this Web site has been prepared for and is intended for viewing exclusively within South Africa. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.